Results 11 to 20 of about 4,554 (207)

Magnetic resonance-guided stereotactic body radiation therapy for pancreatic oligometastases from renal cell carcinoma [PDF]

open access: yesPhysics and Imaging in Radiation Oncology
Stereotactic body radiation therapy (SBRT) may be a non-invasive strategy to treat patients with pancreatic oligometastases from renal cell carcinoma (RCC). We analyzed 11 patients treated with MR-guided SBRT to 31 pancreatic oligometastases. At a median
Jonna K. van Vulpen   +6 more
doaj   +3 more sources

Stereotactic body radiotherapy for oligometastases.

open access: yesThe Lancet Oncology, 2016
The management of metastatic solid tumours has historically focused on systemic treatment given with palliative intent. However, radical surgical treatment of oligometastases is now common practice in some settings.
Tree, A   +9 more
core   +4 more sources

Chemo-Radiotherapy of Oligometastases of Colorectal Cancer With Pegylated Liposomal Mitomycin-C Prodrug (Promitil): Mechanistic Basis and Preliminary Clinical Experience [PDF]

open access: yesFrontiers in Oncology, 2018
Hypo-fractionated radiotherapy and stereotactic body radiotherapy are viable options for treatment of oligometastases. A prodrug of mitomycin-C is under clinical testing as a pegylated liposomal formulation (Promitil) with an improved safety profile over
Esther Tahover   +12 more
doaj   +2 more sources

Stereotactic body radiation therapy on abdominal-pelvic lymph node oligometastases: a systematic review on toxicity [PDF]

open access: yesActa Oncologica
Background and purpose: To review available data on toxicity during and/or after treatment of abdominal-pelvic lymph node oligometastases (A-P LN) with stereotactic body radiation therapy (SBRT) and to provide an overview of adverse events and its ...
Lucy A. van Werkhoven   +5 more
doaj   +2 more sources

Clinical outcomes of percutaneous microwave ablation for pulmonary oligometastases from hepatocellular carcinoma: a retrospective, multicenter study

open access: yesCancer Imaging
Background Pulmonary oligometastases are common in hepatocellular carcinoma (HCC), however, the existing therapeutic options have several limitations. This study aimed to assess the safety and efficacy of microwave ablation (MWA) in the treatment of HCC ...
Gang Wang   +9 more
doaj   +2 more sources

Radiotherapy for Oligometastases and Oligo-Recurrence of Bone in Prostate Cancer [PDF]

open access: yesPulmonary Medicine, 2012
Purpose. To retrospectively evaluate the clinical significance of radiotherapy for oligometastases of bone in prostate cancer (PCa). Methods and Materials.
Ken-ichi Tabata   +10 more
doaj   +2 more sources

Stereotactic Body Radiotherapy for Metachronous Multisite Oligo-Recurrence: A Long-Surviving Case with Sequential Oligo-Recurrence in Four Different Organs Treated Using Locally Radical Radiotherapy and a Review of the Literature [PDF]

open access: yesPulmonary Medicine, 2012
Stereotactic body radiotherapy (SBRT) for oligometastases represents a recent trend in radiation oncology. While abundant data are available regarding the use of SBRT for the treatment of lung or liver oligometastases from various retrospective series ...
Hiroshi Onishi   +15 more
doaj   +2 more sources

Radiotherapy in the management of lung oligometastases

open access: yesCancer/Radiothérapie
National audienceIn recent years, the development of both medical imaging and new systemic agents (targeted therapy and immunotherapy) have revolutionized the field of oncology, leading to a new entity: oligometastatic disease.
Lerouge, D.   +12 more
core   +4 more sources

Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression

open access: yesDiagnostics, 2023
Stereotactic ablative radiotherapy (SABR) may improve survival in patients with inoperable pulmonary oligometastases. However, the impact of pulmonary oligometastatic status after systemic therapy on SABR outcomes remains unclear.
Chin-Beng Ho   +15 more
doaj   +2 more sources

SBRT in the Very Elderly: A Viable Option for Pulmonary Oligometastases? [PDF]

open access: yesCancers (Basel)
Background/Objectives: The global population of individuals aged ≥ 80 years is rapidly growing, leading to an increasing incidence of cancer diagnoses in this age group.
Thomas Seppi   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy